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Xmrk encodes a putative transmembrane glycoprotein of 
the tyrosine kinase family and is a melanoma-inducing 
gene in Xiphophorus. We attempted to investigate the 
biological function of the putative Xmrk receptor by 
characterizing its signalling properties. Since a potential 
Iigand for Xmrk has not yet been identified, it has been 
difficult to analyse the biochemical properlies and 
biological function of this cell surface protein. In an 
approach towards such analyses, the Xmrk extracellular 
domain was replaced by the closely related Iigand-binding 
domain sequences of the human epidennal growth factor 
receptor (HER) and the ligand-induced activity of the 
chimeric HER-Xmrk proteinwas examined. We show 
that the Xmrk protein is a functional receptor tyrosine 
kinase, is highly active in malignant melanoma and 
displays a constitutive autophosphorylation activity 
possibly due to an activating mutation in its extracellular 
or transmembrane domain. In the focus formation assay 
the HER-Xmrk chimera is a potent transfonning 
protein equivalent to other tyrosine kinase oncoproteins. 
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lntroduction 
In multicellular organisms, cell surface receptors play a 
pivotal role in the cornmunication process· of a cell with its 
environment. Receptor tyrosine kinases (RTKs) constitute 
a group of such molecules that possess a specific intracellular 
enzymatic activity, which upon binding of a Iigand, initiates 
a signal transduction process that results in a specific cellular 
response. Questions of major interest center around the 
elucidation of the molecular components of such systems, 
as weil as the biological role that each of the multiple 
Iigand- receptor systems plays. Biochemical analysis is 
complicated by the pleiotropic character and complexity of 
the receptor-activated signal transduction pathways. For 
functional analysis, several animal systems provide 
promising tools where due to a genetic defect affecting the 
ligand-stimulated signal transduction pathway, a specific 
mutant phenotype is evoked. Several such systems exist for 
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sturlies of the physiological functions of RTKs, e.g. the W 
and steelloci of mice, which define functions of the c-Kit 
RTK and its corresponding Iigand (Geissler et al., 1988; 
Williams et al., 1990), the vulval induction locus (let-23) 
of Coenorhabditis elegans (Aroian et al., 1990) and thefaint 
little ball and torpedo mutants of Drosophila (Price et al., 
1989; Schrejter and Shilo, 1989), all ofwhich affect the EGF 
receptor, the sevenless gene encoding a unique Drosophila 
RTK that affects the eye development (for review see Basler 
and Hafen, 1988) and the early developmental RTK torso, 
which is a key component of the Drosophila tenninal 
organizer system (Sprenger et al. , 1989). In addition to their 
physiological function, several RTKs appear as crucial 
effectors in the process of neoplastic transformation. 
The melanoma system of the swordtail fish Xiphophorus 
(for review see Schart! and Adam, 1992), offers a unique 
vertebrate model for the analysis of the physiological function 
of RTKs in tumorigenesis. Xmrk has been identified as the 
melanoma-inducing oncogene in Xiphophorus (Wittbrodt 
et al., 1989). In addition to the oncogenic Xmrk, a second 
homologous copy of the gene representing the proto-
oncogene has been found in the genome of Xiphophorus. 
The nucleotide sequence of the oncogenic Xmrk was obtained 
from a cDNA isolated from melanoma cells. Analysis of 
its predicted primary structure revealed that it contains all 
of the major structural features of a cell surface receptor 
with tyrosine kinase activity. It bears the greatest similarity 
to members of RTK subdass I in its extracellular, 
juxtamembrane and kinase domains (Y arden and Ullrich 
1988; UHrich and Schlessinger, 1990). The predicted Xmrk 
gene product, like all subdass I RTKs, contains an 
uninterrupted cytoplasmic tyrosine kinase domain that is 
connected via hydrophobic transmembrane sequences with 
two cysteine-rich repeat sequences in the extracellular Iigand-
binding domain. While the EGF receptor is known to bind 
EGF, transforming growth factor a (TGFa) and the vaccinia 
virus growth factor, the Iigand of the Xmrk gene product 
is still unknown, and its normal biological role is not yet 
clear. An involvement of the Xrnrk receptor in cellular 
growth control mechanisms is suggested by the fact that 
uncontrolled expression of the Xmrk gene Ieads to formation 
of malignant melanoma in Xiphophorus hybrids (Wittbrodt 
et al., 1989; Adam et al., 1991). 
To understand the function of the Xrnrk protein for the 
process of neoplastic transformation of pigment cells, its 
biochemical and biological properties have to be 
characterized. To study this prior to the identification of its 
specific Iigand, we have constructed a chimeric receptor. 
Using the related, but distinct EGF receptor (human 
epidermal growth factor receptor, HER) Iigand-binding and 
transmembrane domain fused to the cytoplasmic portions of 
Xrnrk, we were able to investigate the signalling function 
of the Xmrk cytoplasmic domain by activation with EGF. 
We demonstrate that Xmrk has the potential to generate a 
normal signal when stimulated by a Iigand and shows 
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constitutive autophosphorylation acttvtty in heterologous 
expression systems. It is highly active and the mostabundant 
phosphotyrosine protein in malignant melanoma of 
Xiphophorus. The HER- Xmrk chimera is a potent 
oncoprotein that readily Ieads to cell transformation upon 
Iigand binding. 
Results 
Expression of Xmrk and of HER- Xmrk chimeric 
receptor in heterologous and homologaus cells 
To express the Xmrk protein transiently, the coding region 
of the Xmrk cDNA was cloned into the eukaryotic expression 
vector pRK5, generating the pRK5mrk construct (Figure 1). 
This expression construct was transfected to 293 cells (human 
embryonie kidney fibroblasts). 
The antiserum directed against the RK-2 peptide, derived 
from the C-terminus of the HER (Kris et al., 1985), was 
expected to cross-react with the Xmrk protein, as it shares 
10 out of 12 amino acids in the corresponding C-terminal 
region (Figure 2a). The RK-2 antiserum specifically 
precipitated a 160 000 polypeptide (or a 160-150 kDa 
doublet) from pRK5mrk transfected 293 cells, but not from 
mock transfected cells (Figure 2b). A protein of the same 
size was detected with the RK-2 antiserum in the lysate of 
PSM cells (Platy-Swordtail melanoma cells), which have 
been shown to express abundantly Xmrk at the RNA Ievel 
(Mäueler et al., 1988; Wittbrodt et al., 1989). No such 
protein was precipitated from the non-tumorous A2 
embryonal cellline. The difference between the predicted 
MW ofthe Xmrk protein (127 kDa) and the apparent MW 
of 160 kDa determined from SDS gels, suggests a post-
translational modification. As the conceptual translation of 
the cDNA predicted 13 N-glycosylation sites in the 
extracellular domain glycosylation is the most probable 
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modification. The identical size of the proteins detected in 
Xmrk-expressing PSM and 293 cells suggests that the fish 
Xmrk protein is correctly expressed and processed in the 
mammalian 293 cell system. 
To examine the biochemical properlies and biological 
signalling potential of the putative growth factor receptor 
Xmrk prior to the identification of its cognate Iigand, we 
replaced its extracellular and transmembrane domain with 
the Iigand-binding domain of HER. The fusion of the 
corresponding cDNAs was carried out at the common Nari 
site (HER bp 2195, Ullrich et al., 1984; Xmrk bp 2028, 
Wittbrodt et al. , 1989) at the intracellular border of the HER 
and Xmrk transmembrane sequence (see Figure 1; Materials 
and methods). The hybrid cDNA was inserted into the 
mammalian expression vector pRK5 to generate the 
pRK5HER-Xmrk expression construct. 
By DNA transfection of human 293 cells were generated 
transiently expressing either the HER- Xmrk chimera or 
wild type HER and Xmrk as controls. 
Immunoprecipitates from lysates of [35S]methionine-
labelled cells using either mAb 108.1, a monoclonal antibody 
directed against extracellular domain m of HER (Lax et al., 
1989) or the polyclonal RK-2 antiserum, both detected a 
protein of 165 kDa. This demonstrated that the chimeric 
molecule synthesized in transfected 293 cells contained 
N-terminal HER sequences as weil as C-terminal structures 
that cross-react with RK2, suggesting a correct translation 
of the HER-Xmrk chimera (Figure 3). The chimeric 
HER-Xmrk protein (calculated MW 127 600 Da) migrated 
in SDS gels with an estimated MW of 165 kDa, suggesting 
correct glycosylation of the EGF receptor extracellular 
domain of HER-Xmrk. , 
No difference was found in the 293 cell system with the 
mAb 108.1 in the expression Ievels of the HER-Xmrk 
chimeric protein and the wild type HER RTK when 
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Fig. 1. Construction and physical maps of expression constructs. To obtain an expression construct for Xmrk, the entire coding sequence of Xmrk 
was removed from the plasmid pBII G4 by digestion with Xbal and Dral, and ligation to the expression vector pRK5, which had been digested with 
Xbal ~d EcoR':'. This resulted in the expression construct pRK5 Xrnrk. For the cloning of a chimeric expression construct, the plasmid pBII G4 
was d1gested w1th Xbal and Narl to remove the sequences encoding the extracytoplasmic portion of the putative protein. The expression plasmid 
CMVneoHER, which contained the entire human EGF receptor gene under the control of the CMV enhancer, was digested with Narl and BamHI, 
and Xbal and BamHI. A 1347 bp Xbal- BamHI fragment and a 848 bp BamHI-Narl fragment, containing the extracellular and transmembrane 
domain-encoding sequences of HERI isolated from the plasmid CMVneoHER, was added to the pBII G4 Xbai-Narl fragment and joined to yield 
the pBII HER-Xrnrk plasmid in a three-f~ctor lig~tion. T~e resulting plasmid contained the extracellular and transmembrane domain encoding 
sequences of HERI fused to the cytoplasnuc dorruun encodmg sequences of Xmrk. This plasmid was cut with Xbal and partially digested with Dral. 
A 3.6 kb Xbal-Dral .frag~ent, containi.ng the entire coding sequence, was Iigated into the expression vector pRK5 which had beendigested with 
Xbal and EcoRV to yteld m the express10n construct pRK5 HER-Xrnrk. The precision of the ligations was confirrned. by sequence analysis. 
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comparing immunoprecipitates from metabolically labelled 
transfected 293 cells (data not shown). 
ln vitro and in vlvo autophosphorylation 
To examine the functional integrity of the HER- Xmrk 
chimera, we tested the ability of the EGF receptor Iigand-
binding domain to activate the kinase of the Xmrk 
cytoplasmic portion upon Iigand-binding in vitro, thus 
resulting in receptor phosphorylation on tyrosine residues. 
293 cells expressing HER or HER- Xmrk were stimulated 
with EGF. Cells were lysed and the crude membrane extract 
was immunoprecipitated with mAb 108.1. Thein vitro kinase 
assay demonstrated that like native HER, the chimeric 
a ,. 
RK-2 peptide 986 DVVDADEYLIPQ 997 
Xmrk-protein 976 ......... L.Y 987 
b IP: aRK-2 
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Fig. 2. Detection of the Xmrk receptor protein in Human embryonie 
kidney fibroblasts (293) transiently expressing Xmrk and non-
transfected fish melanoma cells (PSM). a. Comparison of the RK-2 
peptide and the corresponding region of the Xmrk protein. b. Cells 
were Iabelied with ess]methionine ovemight, lysed and 
immunoprecipitated as described in Materials and methods. Lysates 
were immunoprecipitated with aRK-2 antiserum. Mock-transfected 293 
cells and fish A2 cells not expressing Xmrk were used as controls. 
Molecular weight markers are indicated in kDa. 
IP: aRK-2 mAB108-1 
I HER-"HER-
mock Xmrk Xmrk mock 
200kD 
165kD 
97kD 
293 cells 
Fig. 3. Detection of chimeric HER-Xmrk receptors. 293 cells 
transfected with the chimeric HER- Xmrk expression construct were 
Iabelied with [35S]methionine ovemight, lysed and immunoprecipitated 
with the indicated antisera as described in Materials and methods. 
Mock-transfected 293 cells were used as controls. Molecular weight 
markers are indicated in kDa. 
Xmrk tyrosine kinase activation 
HER- Xmrk protein displays autophosphorylation that can 
be stimulated by EGF in vitro (Figure 4). 
The autophosphorylation of Xmrk and HER- Xmrk was 
further investigated by experiments with living cells utilizing 
phosphotyrosine antibodies. 293 cells that were transiently 
expressing Xmrk or HER-Xmrk were metabolically 
labelled with [35S]methionine and exposed to EGF. The 
reactions were stopped after 10 min by celllysis with Triton 
lysis buffer. Sampies were immunoprecipitated using an 
antibody directed against phosphotyrosine and separated by 
SDS gel electrophoresis. Tyrosine-phosphorylated proteins 
were then detected by autoradiography. 
In cells that were expressing HER-Xrnrk, a band of 165 
kDa was found to be tyrosine-phosphorylated only after EGF 
Stimulation. In the absence of EGF, no tyrosine-
phosphorylated protein could be detected. 
To analyse the chimeric receptor in fish cells, which 
provide a homologous system for the Xmrk kinase, A2 cells 
transiently expressing HER- Xmrk were treated with EGF 
and lysed. Compared with 293 cells, which were transfected 
in a parallel experiment, A2 cells expressed HER-Xmrk 
at much lower levels (data not shown). To prove conclusively 
that the tyrosine-phosphorylated proteins detected represented 
autophosphorylated HER- Xmrk, the samples were 
immunoprecipitated using the mAb 108.1, separated on SDS 
gels, Western blotted and immunoprobed with an antibody 
directed against phosphotyrosine. As shown in Figure 6, 
tyrosine phosphorylation of the chimeric HER-Xmrk 
protein was strongly induced by EGF in HER-Xmrk-
expressing cells, whereas the chimeric RTK was quiescent 
in unstimulated cells. This was equally true for mammalian 
(293) and fish (A2) cells expressing the chimeric RTK. 
Due to the structural similarity of the Xmrk and HER 
extracellular domains, it was reasonable to investigate 
whether other ligands known to stimulate HER kinase 
activity also interact with Xmrk. Metabolically labelled 293 
cells that were expressing Xmrk were treated with EGF, 
lysed, immunoprecipitated using an antibody directed against 
phosphotyrosine and separated by SDS gel electrophoresis. 
Tyrosine-phosphorylated proteins were detected by 
autoradiography. EGF as well as TGFa (data not shown) 
HER 
170 kD-
con-
trol 
+ + 
HER HER-mrk 
II . + I EGF 
5mMMn2+ 
HER-mrk 
165kD 
Fig. 4. Receptor autophosphorylation in vitro. Equal numbers of 293 
cells transiently expressing HER and HER- Xmrk were incubated in 
the presence ( +) or absence (-) of 50 ng/ml EGF, lysed and the 
lysates immunoprecipitated with the monoclonal antibody mAb 108.1. 
In vitro kinase reactions were carried out as described in Materials and 
Methods. Mock-transfected cells were used as control. Molecular 
weight markers are indicated in kDa. · 
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Xmrk 1 Xmrk 5 Xmrk 8 Xmrk 12 
blotting antibody: a mrk 
c 
HER-Xmrk Xmrk 12 
EGF + 
HER-Xmrk Xmrk 
BHKcells 
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Fig. 5. Receptor autophosphorylation in living cells. (a) Equal 
numbers of 293 cells transiently expressing Xmrk and HER-Xmrk as 
weil as A2 and PSM cells were metabolically Iabelied with 
ess]methionine overnight, incubated in the presence ( +) or absence 
(-) of 50 ng/ml EGF, lysed and the lysates immunoprecipitated with 
a monoclonal antibody directed against phosphotyrosine. Mock-
transfected and A2 cells were used as control. Molecular weight 
markers are indicated in kDa. (b) Western blot analysis of BHK cells 
expressing Xmrk. Equal numbers of Xmrk-expressing BHK cells were 
lysed, the proteins were separated by SOS-PAGE, the gels were 
blotted and immunoprobed with the aXmrk serum and detected with 
the ECL chemiluminescence system (Amersham). (c) Analysis of 
tyrosine phosphorylation in stably expressing BHK cells. HER-Xmrk 
and Xmrk-expressing cells were incubated in the presence ( +) or 
absence (-) of 50 ng/ml EGF prior to Iysis. Lysates were separated 
on SOS gels, blotted and the blots were immunoprobed with the aPY 
antiserum and detected with the ECL chemiluminescence system 
(Amersham). " 
were found to have no influence on the phosphorylation Ievel 
of the 160/150 000 double band representing Xmrk 
(Figure 5a). 
In contrast to the HER-Xmrk chimeric protein, in which 
the Xmrk kinase is quiescent unless activated with EGF, 
there was a significant basal activity of the Xmrk kinase in 
293 cells transiently expressing Xmrk (Figure 5a). 
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To further investigate the phenomenon of Xmrk 
autophosphorylation found in transiently expressing 293 
cells, the Xmrk gene and the HER-Xmrk chimera were 
transfected into BHK cells using the CVN vector to obtain 
stably expressing lines. For the chimera two stable lines 
(HM9 and HM8) were generated expressing the receptor 
at low and high Ievels, respectively. Similar to the situation 
in 293 cells the chimeric receptor was not tyrosine-
phosphorylated in the absence ofligand (Figure 5c). Addition 
of EGF led to a strong autophosphorylation. Five lines 
(Xmrk1, 7, 8, 11 and 12) expressed the native Xmrk receptor 
stably at different Ievels (Figure 5b and data not shown). 
In clone Xmrk12 giving the highest expression comparable 
to the expression Ievels of HER- Xrnrk in HM8, a 
constitutive autophorphorylation of Xrnrk was readily 
detected (Figure 5c). 
To analyse Xmrk kinase activity in vivo, PSM fish 
melanoma cells and various normal and tumorous tissues 
of Xiphophorus were used. The imrnunoprecipitation of a 
Triton-X100 lysate of metabolically-labelled PSM melanoma 
cells with an aPY antibody revealed a strongly tyrosine-
phosphorylated band of 160 kDa corresponding to the 160 
kDa Xmrk protein detected with the RK-2 antiserum (Figures 
1 and 5). Biopsies of malignant melanomas of 
maculatus-Xiphophorus helleri hybrids, as weil as of 
normal tissues, were lysed and immunoprecipitated with an 
antiserum raised against Xmrk protein expressed in 
recombinant baculovirus-infected SF9 insect cells 
(Malitschek et al., in preparation). The precipitated proteins 
were separated on SDS gels, Western blotted, and 
immunoprobed with aPY antibodies. 
Xmrk that was precipitated from melanoma biopsies was 
found to be strongly phosphorylated on tyrosine. Gills that 
were demonstrated to express the Xmrk proto-oncogene 
transcript (Wittbrodt et al. , 1989) and Xiphophorus brain 
lysates did not to contain any aXmrk -precipitable tyrosine-
phosphorylated protein (Figure 6). 
In summary, the tyrosine kinase of the chimeric 
HER-Xmrk protein can be activated by human EGF, but 
is inactive in unstimulated cells. The Xmrk protein was found 
to be phosphorylated on tyrosine in Xmrk-expressing 
heterologous cells. In fish melanoma cells and in melanoma 
biopsies, the Xmrk tyrosine kinase is strongly phosphorylated 
on tyrosine. 
Substrate phosphorylation 
Upon activation with their ligands, receptors of the tyrosine 
kinase family induce similar primary responses within cells 
(for review seeUHrich and Schlessinger, 1990). RTKs act 
by phosphorylating substrate proteins on tyrosine and thereby 
activate their substrates. To investigate the substrate 
phosphorylation of the Xmrk kinase upon activation with 
EGF in the HER-Xmrk chimera and compare it with the 
substrate phosphorylation of the HER, we transfected 293 
cells with HER or HER-Xmrk expression constructs and 
stimulated cells with EGF. Triton lysates were directly 
separated on SDS gels, Western blotted and the blots were 
immunoprobed with aPY antibodies. 
In cells that were expressing HER-Xmrk, a tyrosine-
phosphorylated protein of 140 kDa could be detected at 
abundant Ievels after EGF stimulation (Figure 7). In 
unstimulated cells expressing HER-Xmrk this 140 kDa 
phosphoprotein is present at low Ievels, whereas in HER 
Xmrk tyrosine kinase activation 
IP: mAblOS-1 aXmrk 
I HER-mrk 
l • mock + 
mock HER-mrk 
+ I - + EGF + 
293 cells A2 cells Biopsies 
Blotting antibody: cx PY 
Fig. 6. Western blot analysis of the autophosphorylation of the Xmrk kinase domain in heterologous and homologous cells and tissues. Human 293 
cells and fish A1 cells transiently expressing HER-Xmrk were incubated in the presence ( +) or absence (-) of 50 ng/ml EGF. Equal numbers of 
cells were lysed and the Iysates immunoprecipitated with a monoclonal antibody directed against the second cysteine rich domain of HER. 
lmmunoprecipitates were separated on SOS gels, Western blotted and the blots immunoprobed with antibodies directed against phosphotyrosine. 
Tyrosyl phosphorylated proteins were detected by autoradiography after incubation with [125I]protein A. (Mock-transfected and A2 cells were used as 
control.) Triton lysates of indicated tissues were immunoprecipitated with a polyclonal antiserum directed against baculovirus expressed Xmrk. 
lmmunoprecipitates were separated on SOS gels, Western blotted and immunoprobed with antibodies directed against phosphotyrosine. Tyrosine-
phosphorylated proteins were detected by chemoluminescence with an HRP coupled second anti-rabbit antibody. Molecular weight markers are 
indicated in kDa. 
HER HER-mrk mock 
EGF II + - II + 
HER 
170 kD· 
148 k.D-: 
Plcy ' 
Plcy+ 
I mock HER HER-mrk I 
1- +11- +II. +I EGF 
-~ -165kD UER·mrk 
Blotting antibody: a PY 
Fig. 7. EGF-stimulated in vivo phosphorylation of receptor substrates. a. Confluent monolayers of cells transiently expressing HER and HER-Xmrk 
as weil as mock transfected cells were incubated in the presence ( +) or absence (-) of 50 ng/ml EGF. Following stimulation, equal amounts of 
cells were lysed and lysates were directly separated on SDS gels. After Western blotting, membranes were immunoprobed with an antibody directed 
against phosphotyrosine and tyrosine-phosphorylated proteins -detected by chemoluminescence after incubation with an HRP cotipled second anti-
mouse antibody. (Mock-transfected 293 cells were used as control.) b. Equal numbers of cells cotansfected with PLC-y and HER or HER- Xmrk or 
control ONA were Iysed and the lysates separated on SOS gels, Western blotted and the blots immunoprobed with antibodies directed against 
phosphotyrosine. Tyrosine-phosphorylated proteins were detected as above. Molecular weight markers indicated are in kDa. 
and mock controls it is barely detectable. A second less 
prominent candidate substrate of the Xmrk kinase in 293 cells 
bad an approximate MW of 105 kDa. A 72 kDa protein was 
found to be tyrosine-phosphorylated in HER- and 
HER-Xmrk-expressing cells after Stimulation with EGF 
(Figure 7). 
A prominent substrate of HER is PLC-y, which becomes 
tyrosine phosphorylated (Margolis et al., 1989; Meisenhelder 
et a/., 1989; Wahl et a/., 1989) and thereby activated 
(Nishibe et a/., 1990) in HER-expressing cells upon 
stimulation with EGF. C-terminal autophosphorylation sites 
have tobe phosphorylated for a receptor/PLC-y interaction 
(Margolis et a/., 1990). The high similarity of HER and 
Xmrk, and the conservation of the autophosphorylation sites 
suggested that PLC-y may also be a substrate for the Xmrk 
kinase. To analyse the interaction of the Xmrk fish tyrosine 
kinase and human PLC-y, 293 cells were cotransfected with 
PLC-y and HER-Xmrk expression constructs and treated 
as described above. Cells coexpressing HER and PLC-y 
exhibited strong phosphorylation of the 170 kDa receptor 
protein and the 148 kDa PLC-y even in the absence ofEGF. 
The tyrosine phosphorylation of the HER- Xmrk chimera 
was stimulated by EGF, but only a very faint band of 148 
kDa representing the tyrosine-phosphorylated PLC-y was 
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detected in the EGF-stimulated cells coexpressing HER-
Xmrk and PLC.y (Figure 7b). 
Several potential substrates of the Xmrk tyrosine kinase, 
different from substrates of HER appeared to be tyrosine-
phosphorylated after EGF treatment of HER-Xmrk-
expressing 293 cells. However so far, human PLüy cannot 
be classified as a major substrate of the fish Xmrk kinase 
in the coexpression assay. Further experiments are needed 
to clarify this point. 
Transfonning ability of the HER-Xmrlc chimera 
To investigate whether the HER-Xmrk chimera mediates 
growth signals in a heterologous system, NIH 3T3 cells were 
infected with replication defective retroviruses that carry the 
cDNAs coding for Xmrk or HER-Xmrk. No foci were 
obtained in the Xmrk infected cells neither in the presence 
nor absence of EGF. A low Ievel of foci formation was 
observed in the HER-Xmrk expressing cells without addition 
of exogenous EGF (1.2 foci/163 viruses). This can be 
explained by unavoidable remnant traces of EGF in the tissue 
culture medium. In the presence of EGF the number of foci 
was dramatically increased to one focus/virus. 
Discussion 
We have constructed a receptor chimera to initiate the 
characterization of the biochemical and biological functions 
of Xmrk and thereby its yet unidentified Iigand. This 
approach has previously been successful in creating 
functional insulin- IGF1 receptors, insulin- EGF receptor 
chimera and HER1-HER2 hybrids (Riedel et al., 1986; 
Lammers et al., 1989; Lee et al., 1989, Lehväslaiho et al., 
1989). Using the EGF receptor Iigand-binding domain fused 
to the Xmrk cytoplasmic domain, we were able to investigate 
various aspects of biological signalling activities normally 
induced through the Xmrk molecule by its currently 
unknown Iigand. The HER-Xmrk chimera was correctly 
synthesized, processed and transported to the cell surface. 
Ligand-induced autophosphorylation is thought to be a 
crucial step in the process of receptor-mediated signalling. 
Defects in this process either Iead to a loss of biological 
activity or constitutive activation or loss of control. It has 
been shown that Iigand binding to a receptor chimera results 
in activation of the heterologous receptor kinase and 
autophosphorylation in vitro andin living cells (Riedel et al., 
1986; Lammers et al., 1989; Lee et al., 1989; Lehväslaiho 
et al., 1989). This process is also functional in the 
HER-Xmrk receptor hybrid. In vitro as weil as in intact 
cells, the stimulation of the HER-Xmrk chimera with EGF 
led to the induction of the intracellular tyrosine kinase, as 
measured by the degree of receptor autophosphorylation. 
This confirms that a heterologous cytoplasmic domain does 
not disturb the formation of an authentic binding site 
conformation by EGF receptor extracellular sequences, even 
between domains that have undergone as much as 900 million 
years of independent evolutions. 
In addition to retaining full kinase activity, HER-Xmrk 
was also able to generate an apparently Xmrk-specific signal 
that resulted in phosphorylation of cellular protein substrates. 
This demonstrates that despite the high similarity of HER 
and Xmrk in their primary structure, receptor-specific signals 
may be generated within a < single cell type by specific 
phosphorylation of different substrates. These specific 
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substrates offer the opportunity to dissect the kinase domain 
in chimeric RTKs and thereby define the subdomains that 
confer to substrate specificity, in an approach similar to the 
characterization of the Iigand-binding domain (Lax et al., 
1989). . 
Despite these differences in substrate specificity the high 
transforming activity of the HER-Xmrk chimera in NIH 
3T3 cells dramatically shows the conservation of at least 
some components of the signalling pathways. The signal 
transducing machinery of the mammalian cells is obviously 
perfectly able to interact structurally and functionally with 
the fish receptor intracellular domain and elicit the same 
response as if it would be activated by a homologous 
molecule. 
The native Xmrk protein is abundantly autophosphorylated 
in fish melanoma cells, where it is clearly the transforming 
oncogene. To explain the autophosphorylation of the Xmrk 
protein in transiently expressing 293 cells and stably 
expressing BHK cells, several arguments have to be 
considered. Firstly, this autophosphorylation may be a 
consequence of the high expression. However, the 
HER-Xmrk chimera, which is expressed under the control 
of the same promoter at similar Ievels, did not show 
detectable autophosphorylation without its Iigand. In 
addition, in stable lines the expression Ievel is much lower 
than in transient expression systems. The Ievel of constitutive 
autophosphorylation of Xmrk was considerably lower than 
the autophosphorylation obtained after stimulation of HER 
or HER-Xmrk with the cognate Iigand. It was detectable 
only in that stable BHK line which expresses the highest Ievel 
of Xmrk. Secondly, the heterologous cells could produce 
a stimulatory factor for Xmrk. This explanation does not 
seem to be very likely in the light of the large evolutionary 
distance of fish and humans, because even the chicken EGF 
receptor is not able to recognize mammalian EGF with 
sufficient affinity (Lax et al., 1989). Thirdly, Xmrk might 
carry an activating mutation in its extracellular or 
transmembrane domain, which then would be responsible 
for autostimulation. Sirnilar phenomena have been observed 
in carcinogen-induced tumours of rats, where the neu 
oncogene was found to bear an activating mutation in the 
transmembrane domain (Bargmann and Weinberg, 1988; 
Stern et al., 1988) and in v-fms, where point mutations in 
the extracytoplasmic portion led to an intracellular activation 
ofthe kinase (Roussel et al., 1988; Woolford et al., 1988). 
In the focus formation assay the native Xmrk RTK did 
not show any transforming ability. This may indicate that 
a low Ievel of constitutive tyrosine phosphorylation at least 
in the heterologous cells is not sufficient to elicit a 
tumorigenic effect. From this it can be extrapolated that an 
activating mutation alone may not be the exclusive reason 
for the oncogenic function of Xmrk in neoplastic 
transformation of pigment cells. Further experiments are 
needed to clarify these points. 
The complexity of Xmrk action is even higher if the in 
vivo situation of melanoma induction in Xiphophorus is 
considered. Interestingly, in the Xiphophorus melanoma 
system, the same gene that is" responsible for tumour 
induction in hybrids is also present in the tumour-free 
parental feral animals. In addition to activation at the protein 
Ievel, an alteration of the transcriptional control of the Xmrk 
gene by the crossing conditioned elimination of a tumor 
suppressor locus (Adam et al., 1991) is crucial for neoplastic 
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transformation in vivo. Only unscheduled overexpression 
of the Xmrk oncogene in pigment cells of hybrid genotypes 
is the precondition to initiate the processes of Xmrk mediated 
tumorigenesis. 
With this perspective, the Xiphophorus melanoma system 
provides not only a unique vertebrale model for the analysis 
of RTK function in melanoma formation, but also for 
suppression of RTK-mediated tumorigenesis. 
Materials and methods 
Antibodies 
mAb 108.1 recognizes the extracellular domain of the human EGF receptor 
(Lax et a/., 1989), aPY was a monoclonal antibody directed against 
phosphotyrosine. Rabbit antiserum RK-2 recognizes residues 984-996 of 
the human EGF receptor (Kris et al., 1985). Rahbitantiserum aXmrk was 
raised against Xmrk expressed in recombinant baculovirus infected SF9 iruect 
cells (Malitschek et al., in preparation). 
Expression plasmids 
The clone pBll G4, which contains the entire coding sequence of Xmrk, 
was generated by ligation of the extracellular and transmembrane domain 
containing clone p3-2E to the cytoplasmic domain containing clone p17-2 
(Wittbrodt er al., 1989) via the common EcoRI site (2153) in pBluescript 
n (Stratagene). The expression constructs for Xmrk and HER- Xmrk were 
cloned as described in Figure 1. 
The construct CMVneoHER which contained the entire human EGF 
receptor gene under the control of the CMV enhancer, was used for HER 
expression. To produce the stably expressing BHK cell lines, the 
HER- Xmrk and Xmrk coding sequences were cloned in the CVN vector 
(Rosenthal et al., 1986) by utilizing the Xbal and Dral sites of the cDNAs 
and the Xbal and EcoRV sites in the vector. 
For the production of ectotropic retroviruses, the cDNAs of Xmrk and 
HER- Xmrk were cloned into the retoroviral expression vector pLXSN 
(Miller and Rosman, 1989). From the pRK constructs the cDNAs were 
isolated by a Xbal/ Dral partial digest for HER- Xmrk and Hindlll/ EcoRI 
partial digest for the Xmrk cDNA and Iigated into Hpal or Hpall EcoRI 
linearized vector. 
The PLC-y expression construct for the coexpression experiments was 
obtained from J. Schlessinger. 
Ce// cu/ture and transfections 
293 human embryonie kid.ney fibroblasts were cultured in DMEM containing 
10% fetal calf serum. Expression vectors were introduced into 293 cells 
by the method of Chen and Okayama (1987). 4 1-'g of supercoiled plasmid 
DNA were used per 3 cm dish. 15 h after transfection, the precipitate was 
removed from the cells by washing with PBS and cells were fed with fresh 
medium. Cell Iysis was perfonned 36-40 h after transfection. A2 fish 
embryonal fibroblasts were cultured in Fl2 medium containing 10% fetal 
calf serum. Expression vectors were transfected into A2 cells as described 
earlier (Friedenreich and Schart), 1990). BHK-21 cells were grown in 
DMEM/Fl2 mix supp1emented with 10% fetal calf serum and antibiotics. 
DNA precipitate was prepared as above and added to 2 x tOS cells in a 
3 cm dish. For selection, a puromycin resistance encoding plasmid (pSV2pac) 
was -cotransfected in a molar ratio of 1: 10. Transfeeted cells were selected 
in growth medium with 30 1-'g/ml of puromycin (Wirth et al., 1988). 
Individual clones were picked and analyzed for expression. 
The expression constructs pLXSN-Xmrk and pLXSN-HER-Xmrk were 
introduced into GP + E-86 cells by transfection which then produced 
ecotropic retrovirus. The virus for the focus fonnation assay was derived 
from cell culture supernatants of these GP + E-86 cells. 
Focus formatlon assay 
For the focus fonnation assay, tOS NIH 3T3 cells were seeded in 6 cm 
dishes and 24 h later, virus and 6 mg/ml polybrene were added. After 36 h 
the cells were trypsinized and reseeded into 10 cm dishes. The medium, 
containing 4% fetal calf serum, was changed every other day until foci 
appeared. For stimulation 10 ng/ml of EGF was added to the culture medium. 
Metabolie /abelling 
For metabolic labelling of proteins in transiently expressing cells, cells were 
incubated 24 h after transfection with I ml of methionine-free medium 
containing 1% dialyzed fetal calf serum, 2 mM L-glutamine, antibiolies and 
Xmrk tyrosine kinase activation 
50 1-'Ci/ml [35S]methionine per 3 cm dish. The incubation was continued 
for 16 h. 
lmmunoprecipitation and Western b/otting 
To detect and characterize receptor proteins, cell monolayers were lysed 
in the dishes 36-40 h after transfection in 300 1-'llysis buffer (20 mM HEPES 
pH 7.2, 150 rnM NaCI, 10% glycerol, I% Triton X-100, 1.5 mM MgCI2, 
1 mM EGTA, 2 rnM phenylmethylsulfonyl fluoride arxl200 U/ml aprotinin). 
Dishes with Iysis buffer were incubated on ice for 5 min, the supematant 
was collected, incubated on ice for further 5 min, centrifuged at 14 000 
g for 5 min and the supernatant was used for imrnunoprecipitation. The 
supernatant was diluted 1:3 with HNTG (20 mM HEPES pH 7.2, 150 mM 
NaCI, 10% glycerol and 0.1% Triton X-IOO),and incubated with 1-5 1-'1 
antiserum and 20 "'' of protein A- Sepharose (1 : 1 slurry in HNTG buffer) 
for at least 2 h at 4 oc. The immunoprecipitates were washed three times 
in 0.5 ml HNTG buffer. For analysis of tyrosine phosphorylation, cells 
were lysed and washed in lysis/HNTG buffer containing 100 mM NaF and 
100 1-'M sodium orthovanadate. The pellet was then resuspended in 50 ~tl 
of2xSDS gel sample buffer. Sampies were boiled for 5 min, centrifuged 
and analysed on 7.5% SDS-polyacrylamide gels. 
Gels containing proteins Iabeiied with ess]rnethionine were flXed for 30 
min in 10% acetic acid-25% isopropanol, incubated for 1 hin Amplify™. 
dried under vacuum at 80°C and exposed. 
For total membrane extracts, the cells were lysed in 200 1-'1 of Iysis buffer-
After centrifugation of the lysates, 50 ~o~l of the supematant were added to 
50 1-'1 of sample loading buffer, boiled for 30 rnin with the Iids of the reaction 
tubes being open and electrophoresed on 7.5% SDS-polyacrylamide gels. 
The proteins were transferred to nitrocellulose (Schleicher and Schuell) 
using standard Western bloning protocols. 
Filters were blocked for 2 x30 min with NET-G (150 mM NaCI, 5 mM 
EDTA, 0.05 % Triton X-100 and 0.25% gelatine) and treated 6 h with 
monoclonal antiphosphotyrosine antibod~ at 4 oc, washed three times for 
30 min in NET-G, incubated in [12 I]protein A for 2 h at room 
temperature, washed three times and exposed to X-ray film. 
Non-radioactive detection (ECL-Amersharn) was performed according 
to suppliers recornmendations after blocking and incubation with first 
antibody. 
ln vitro phosphorylation assay 
To detennine receptor autophosphorylation activity, confluent 3 cm dishes 
of transfected cells were stimulated with EGF (100 ng/ml), lysed with Iysis 
buffer as above and imrnunoprecipitated with mAb 108.1. The 
immunoprecipitate was resuspended in 10 ~o~I HNTG-P containing 10 rnM 
MnCI2, 10 1-'Ci of [-y-32P]ATP were added to the irnmunoprecipitate and 
incubated 60 s on ice. 50 1-'1 of hot sample buffer were added to terminale 
the reaction. Sampies were then electrophoresed on 7.5% SDS-
polyacrylamide gels. Dried gels were exposed to Kodak X-Ornat AR ftlm. 
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